Filipe Assoreira and José Albuquerque, president and secretary general respectively of P-Bio – Portugal’s bioindustry association – discuss the…

Paulo Teixeira shines a light on Pfizer’s promising pipeline for 2018, the market access environment in Portugal and the clinical trial landscape.…

João Vasconcelos was the Secretary of State for Industry in Portugal over a two year period, terminating in July 2017, over which time he laid the…

Pedro Moura is the first Portuguese managing director of Merck in Portugal, taking on the role in September 2017 after a stint in HQ in Darmstadt,…

Enrique Santos, president of the Spanish Chamber of Commerce in Portugal since 1998, observes the rapid change in the volume and nature of investments…

Azevedos is one of the oldest pharmaceutical brands in Portugal. Lead by Thebar Miranda, president for 30 years it operates across Portuguese speaking…

Florian Ibe, managing director at Bayer Portugal, discusses market access hurdles, as well as Portugal’s expertise in scientific and clinical…

Paulo Lilaia, president of the board of APOGEN and CEO of Generis, highlights the need for generics in the healthcare system and the government’s…

The Portuguese secretary of state for industry invites readers to discover the vibrant tech landscape in Portugal. Ana Teresa Lehmann unravels the…

Filipa Costa returned to Portugal in September 2016 to take on the leadership of the fastest growing multinational affiliate in the country - Janssen.…

Heitor Costa, Executive Director for APIFARMA, the Portuguese Pharmaceutical Industry Association, outlines the recent improvements in industry and…

A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other developed European markets, with a…